Skip to main content

Advertisement

Log in

Utility of N-Terminal Brain Natriuretic Peptide Plasma Concentrations in Comparison to Lactate and Troponin in Children with Congenital Heart Disease Following Open-Heart Surgery

  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

We conducted a prospective study in a pediatric cardiac intensive care unit in order to determine the diagnostic value of N-terminal brain natriuretic peptide (N-BNP) plasma concentration in the perioperative care of children with congenital heart disease (CHD). N-BNP plasma concentrations were determined by using a validated enzyme immunoassay. We measured N-BNP the day before surgery and up to 15 days postoperatively in 23 children (age range, 0.25–11 years) undergoing cardiac surgery due to various CHDs. Supply and duration of catecholamines, vasodilators, and respiratory therapy were determined and correlated to N-BNP. In addition, troponin T (TnT) and arterial Lactat (aL) concentrations were measured simultaneously. We found a significant correlation between preoperative and maximal N-BNP levels and dosage of vasodilators (r = 0.41, p < 0.02 and r = 0.83, p < 0.01, respectively). Maximal TnT and aL levels were not correlated to dosage of vasodilators. The dosage and duration of catecholamines, the duration of respiratory therapy, and the plasma concentration of TnT and aL were not correlated to pre- or perioperative N-BNP. Maximal TnT and aL levels were correlated to duration (r = 0.53, p < 0.01 and r = 0.48, p < 0.02) and dosage (r = 0.52, p < 0.02 and r = 0.60, p < 0.01) of catecholamines and duration of respiratory therapy (r = 0.57, p < 0.01 and r = 0.50, p < 0.02). As recent studies show, N-BNP appears to be a powerful neurohumoral indicator of ventricular function and prognosis for guiding therapy in the outpatient department or for discriminating cardiac from noncardiac symptoms. In contrast, the value of N-BNP for guiding perioperative therapy in pediatric cardiac intensive care units is limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ationu A, Singer DRJ, Smith A, et al. (1993) Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27:1538–1541

    CAS  PubMed  Google Scholar 

  2. Berendes E, Schmidt C, Van Aken H, et al. (2004) A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 98:11–19

    CAS  PubMed  Google Scholar 

  3. Clerico A, Emdin M (2004) Diagnostic accurancy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50:33–50

    CAS  PubMed  Google Scholar 

  4. Costello JM, Backer CL, Checcia PA, et al. (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25:347–353

    Article  CAS  PubMed  Google Scholar 

  5. Cowie MR, Mendez GF (2002) BNP and congestive heart failure. Prog Card Vasc 44:293–321

    CAS  Google Scholar 

  6. Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25:336–340

    Article  CAS  PubMed  Google Scholar 

  7. Georges A, Forestier F, Valli N, et al. (2004) Changes in type B natriuretic peptide concentrations during cardiac valve replacement. Eur J Cardio Thorac Surg 25:941–945

    CAS  Google Scholar 

  8. Hjortdal VE, Stenbog EV, Ravn HB (2000) Neurohumoral activation late after cavopulmonary activation. Heart 83:439–443

    Article  CAS  PubMed  Google Scholar 

  9. Hutfless R, Kazanegra R, Madani M, et al. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873–1879

    Article  CAS  PubMed  Google Scholar 

  10. Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875–878

    Article  CAS  PubMed  Google Scholar 

  11. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 25:341–346

    Article  CAS  PubMed  Google Scholar 

  12. Levin E, Gardner D, Samson W (1998) Natriuretic peptides. N Engl J Med 339:321–327

    Article  CAS  PubMed  Google Scholar 

  13. Maisel A (2001) B-type natriuretic peptide levels: a potential novel “white count” for congestive heart failure. J Card Failure 7:183–193

    CAS  Google Scholar 

  14. Maisel A, Krishnaswamy P, Nowak RM, et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167

    CAS  PubMed  Google Scholar 

  15. McDonagh TA, Cunningham AD, Morrison CE, et al. (2001) Left ventricular dysfunction, natriuertic peptides, and mortality in an urban population. Heart 86:21–26

    Article  CAS  PubMed  Google Scholar 

  16. Mir TS, Falkenberg J, Friedrich B, et al. (2005) Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young 15:396–401

    Article  PubMed  Google Scholar 

  17. Mir TS, Flato M, Falkenberg J, et al. (2005) Plasma concentrations of N-terminal-pro brain natriuretic peptide in healthy children, adolescents and young adults: effect of age and gender. Pediatr Cardiol 17, DOI: 10.1007/s00246-005-1022-y

  18. Mir TS, Laux R, Hellwege HH, et al. (2003) Plasma N-terminal pro-atrial-natriuretic peptide and plasma N-terminal pro-brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112: 896–899

    Article  PubMed  Google Scholar 

  19. Mir TS, Marohn S, Läer S, et al. (2002) Plasma concentrations of N-terminal-pro brain natriuretic peptide in children from neonatal period to adulthood and in children with congestive heart failure. Pediatrics 110:1–6

    Article  Google Scholar 

  20. Muta H, Ishii M, Maeno Y, et al. (2002) Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Pediatr 91:649–652

    Article  CAS  Google Scholar 

  21. Piper SN, Kumle B, Roehm KD, et al. (2003) Influence of cardiopulmonary bypass on the natriuretic peptides ANP and BNP. Anästhesiol Intensivmed Notfallmed Schmerzther 38:463–469

    CAS  PubMed  Google Scholar 

  22. Sagnella A (2001) Measurement and importance of plasma brain natriuretic peptide and related peptides. Ann Clin Biochem 38:83–93

    Article  CAS  PubMed  Google Scholar 

  23. Talwar S, Siebenhofer A, Williams B, Ng LL (2000) Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal pro BNP. Heart 83:278–282

    Article  CAS  PubMed  Google Scholar 

  24. Troughton RW, Frampton CM, Yandle TG, et al (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126–1130

    Article  CAS  PubMed  Google Scholar 

  25. Winter WE, Elin RJ (2004) The role and assessment of ventricular peptides in heart failure. Clin Lab Med 24:235–274

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to all the doctors and nurses of the pediatric cardiologic department at the University Hospital in Hamburg for excellent support of this study. Biomedica gave no financial support and had no input into the study design or the data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T.S. Mir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mir, T., Haun, C., Lilje, C. et al. Utility of N-Terminal Brain Natriuretic Peptide Plasma Concentrations in Comparison to Lactate and Troponin in Children with Congenital Heart Disease Following Open-Heart Surgery. Pediatr Cardiol 27, 209–216 (2006). https://doi.org/10.1007/s00246-005-1152-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-005-1152-8

Keywords

Navigation